Table 2.
Anticancer drugs in the regulation of ROS levels
| Name | Mechanism of action | Effects on ROS | Cancers | Refs |
|---|---|---|---|---|
| 5-Fu | Inhibits thymidylate synthetase and/or incorporates into RNA and DNA | Induces intracellular increase in O2•- levels | CRC | [137] |
| Tamoxifen | Promotes cancer cell senescence |
Promotes ROS generation | CRC | [159] |
| Celecoxib | Inhibits COX2 activity, Induces ER stress by causing leakage of calcium from the ER into the cytosol |
Induction of ROS owing to ER stress |
CRC | [150] |
| Methotrexate | Triggers ROS related cell apoptosis |
Promotes ROS generation | Different types of cancer | [160] |
| Irinotecan | Topoisomerases inhibitor | Promotes ROS generation | Different types of cancer | [161] |
| Mitoxantrone | Trigging cell membrane scrambling |
Promotes ROS generation | Different types of cancer | [162] |
| Paclitxel(Taxol) | Inhibitor of cell division | Promotes ROS generation | Different types of cancer | [163] |
| Adriamycin | Reduces cell viability through initiating cell apoptosis and strong G2/M phase cell cycle arrest |
Promotes ROS generation | Different types of cancer | [164] |
| Imatinib | Protein tyrosine kinase inhibitor that induce apoptosis |
Promotes ROS generation | Different types of cancer | [165] |
| Camptothecin | Quinolone alkaloid that induces cytotoxicity |
Promotes ROS generation | Different types of cancer | [166] |
| Carboplatin | Cell cycle arrest | Induction of ROS owing to ER stress | Different types of cancer | [167] |
| Capecitabine | Prodrug that is enzymatically converted to 5-Fu in the body |
Promotes ROS generation | CRC | [168] |
| Cisplatin | Inducing nuclear DNA adducts |
Induces a mitochondrial dependent ROS generation | Different types of cancer | [169] |
| Manumycin | Increasing the ROS production and blocking PI3K/AKT pathway | Promotes ROS generation | CRC | [170] |
| Cribrostatin 6 | Quinone containing product induces apoptotic cell death | Promotes ROS generation | Different types of cancer | [171] |